Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

Cited by (730)

Items 301–400 of 730

  1. Protein phosphatase 6 (Pp6) is crucial for regulatory T cell function and stability in autoimmunity
    Wei Cai, Junxun Zhang, Hong Zhou, Xiangxiao Li, Fangzhou Lou, Yang Sun, Zhenyao Xu, Jing Bai, Qianqian Yin, Zhikai Wang et al. · 2021 · Genes & Diseases
  2. The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases
    Huimin Zhou, Lingxiang Mao, Huaxi Xu, Shengjun Wang, Jie Tian · 2022 · Cytokine & Growth Factor Reviews
  3. FOXP3 and SQSTM1/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma
    Shuohui Liu, Honglong Zhang, Jun Yan, Jun Wei Zhu, Zhongtian Bai, Xun Li · 2022 · Pathology - Research and Practice
  4. Bifidobacteria shape antimicrobial T-helper cell responses during infancy and adulthood
    Katrin Vogel, Aditya Arra, Holger Lingel, Dirk Bretschneider, Florian Prätsch, Denny Schanze, Martin Zenker, Silke Balk, Dunja Bruder, Robert Geffers et al. · 2023 · Nature Communications
  5. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells
    Leticia Martín‐Cruz, Marcos Viñuela, Ioanna Kalograiaki, Alba Angelina, Paola Oquist-Phillips, Irene Real-Arévalo, Francisco Javier Cañada, José Ignacio Tudela, Luis M. Moltó, Jesús Moreno Sierra et al. · 2023 · Cellular and Molecular Immunology
  6. TNFR2 signalling in inflammatory diseases
    Richard O. Williams, Felix I. L. Clanchy, Yi-Shu Huang, Wen-Yi Tseng, Trevor W. Stone · 2024 · Best Practice & Research Clinical Rheumatology
  7. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
    Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, M. Napolitano, Sonia Desicato, A. Fragale, C. D'Alterio, A. Trotta, C. Ieranò et al. · 2024 · British Journal of Cancer
  8. Novel insights: crosstalk with non-puerperal mastitis and immunity
    Yao Zhou, Jie Gong, Xianguang Deng, Lele Shen, Lifang Liu · 2024 · Frontiers in Immunology
  9. JunB Controls Intestinal Effector Programs in Regulatory T Cells
    Joshua D. Wheaton, Maria Ciofani · 2020 · Frontiers in Immunology
  10. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells
    Mark D. Mannie, Kayla B. DeOca, Alexander G. Bastian, Cody D. Moorman · 2020 · Cellular Immunology
  11. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function
    Aiting Wang, Mengdi Yang, Rui Liang, Fangming Zhu, Fuxiang Zhu, Xinnan Liu, Yichao Han, Ruirong Lin, Xiaoxia Wang, Dan Li et al. · 2020 · Frontiers in Immunology
  12. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma
    Chengzhi Gao, Guangming Zhou, Min Cheng, Lan Feng, Pengbo Cao, Gangqiao Zhou · 2022 · Frontiers in Genetics
  13. Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer
    Hao Zhang, Chenglong Liu, Qiushi Chen, Lian Shen, Wenting Xiao, Jiayi Li, Yonghui Wang, Di Zhu, Qingwei Zhang, Jianqi Li · 2023 · Journal of Medicinal Chemistry
  14. Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation
    Xin Wang, Lina Sun, Biao Yang, Wenhua Li, Cangang Zhang, Xiaofeng Yang, Yae Sun, Xiaonan Shen, Yang Gao, Bomiao Ju et al. · 2023 · Journal of Clinical Investigation
  15. Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome
    Qilin Chen, Huimin Jiang, Rong Ding, Jinjie Zhong, Longfei Li, Junli Wan, Xiaoqian Feng, Liping Peng, Xia Yang, Han Chen et al. · 2023 · Frontiers in Immunology
  16. Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells
    Shuang Chen, Caihua Li, Zeng Tu, Tao Cai, Xinying Zhang, Lei Wang, Ruoyuan Tian, Jinglan Huang, Yuxuan Gong, Xiaotong Yang et al. · 2024 · Frontiers in Pharmacology
  17. Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
    Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao et al. · 2024 · OncoImmunology
  18. Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs
    Cuicui Guo, Xiaodong Dai, Yulei Du, Xiumei Xiong, Xun Gui · 2024 · Cancer Immunology Immunotherapy
  19. Dual-engineered Treg-Exosome-IKVAV nanovesicles spatiotemporally sequentially regulate neuro-immune microenvironment to promote spinal cord injury repair
    Xin‐Jin Su, Gu Changjiang, Feihui Zeng, Ziheng Wei, Kong Qingjie, Sun WeiJin, Zhu Chao, Xiongsheng Chen · 2026 · Journal of Nanobiotechnology
  20. CaMK4 promotes abortion‐related Th17 cell imbalance by activating AKT/mTOR signaling pathway
    Shuo Chang, Tailang Yin, Fan He, Jinli Ding, Ye Shang, Jing Yang · 2020 · American Journal of Reproductive Immunology
  21. The Effect of Intratumoral Interrelation among FOXP3+ Regulatory T Cells on Treatment Response and Survival in Triple-Negative Breast Cancer
    Noriko Goda, Chika Nakashima, Ichiro Nagamine, Sunao Otagaki · 2022 · Cancers
  22. Treatment of EAE Mice with Treg, G-MDSC and IL-2: a New Insight into Cell Therapy for Multiple Sclerosis
    Mohammad Mehdi Ghorbani, Touraj Farazmandfar, Saeid Abediankenari, Hadi Hassannia, Zahra Maleki, Majid Shahbazi · 2022 · Immunotherapy
  23. Single-cell RNA sequencing reveals the suppressive effect of PPP1R15A inhibitor Sephin1 in antitumor immunity
    Rongjing Wang, Yuchao Zhang, Shiwei Guo, Siyu Pei, Wei Mei Guo, Zhenchuan Wu, Hailong Wang, Minghui Wang, Yizhe Li, Yufei Zhu et al. · 2023 · iScience
  24. Autoimmunity: A New Focus on Nasal Polyps
    Jingyu Huang, Yu Xu · 2023 · International Journal of Molecular Sciences
  25. Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing
    Lele Song, Yuan Gong, Erpeng Wang, Jianchun Huang, Yuemin Li · 2024 · Therapeutic Advances in Medical Oncology
  26. Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer
    Yue Wang, Hanbing Wang, Tao Shi, Xueru Song, Xin Zhang, Yue Zhang, Xuan Wang, Keying Che, Yuting Luo, Lixia Yu et al. · 2024 · EMBO Molecular Medicine
  27. Advances in the Study of CD8+ Regulatory T Cells
    Xiaolei Tang, Vipin Kumar · 2019 · Critical Reviews in Immunology
  28. Organized immune cell interactions within tumors sustain a productive T-cell response
    Maria Andrea Cardenas, Nataliya Prokhnevska, Haydn Thomas Kissick · 2020 · International Immunology
  29. A novel immune-related prognostic signature in epithelial ovarian carcinoma
    Tong Su, Panpan Zhang, Fujun Zhao, Shu Zhang · 2021 · Aging
  30. Standing Variations Modeling Captures Inter-Individual Heterogeneity in a Deterministic Model of Prostate Cancer Response to Combination Therapy
    Harsh Vardhan Jain, Inmaculada C. Sorribes, Samuel K. Handelman, Johnna Barnaby, Trachette Levon Jackson · 2021 · Cancers
  31. A deficient MIF-CD74 signaling pathway may play an important role in immunotherapy-induced hyper-progressive disease
    Jiahui Wang, Jinsheng Hong, Feiyu Yang, Fangming Liu, Xiangdong Wang, Zan Shen, Duojiao Wu · 2021 · Cell Biology and Toxicology
  32. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
    M. Vasconcelos, Maynara Santana-Gonçalves, Djúlio César Zanin-Silva, Kelen Cristina Ribeiro Malmegrim, Maria Carolina Oliveira · 2022 · Frontiers in Immunology
  33. Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
    Jie Wang, Xiaobo Bo, Changcheng Wang, Yanlei Xin, Lingxi Nan, Rongkui Luo, Lingli Chen, Xiao Shi, Tao Suo, Xiaoling Ni et al. · 2019 · Cancer Science
  34. Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis
    Sara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, Alexandra Cîrciumaru, Christina Gerstner, Linda Mathsson‐Alm, Bruno Raposo, Anatoly P. Dubnovitsky, Lars Rönnblom, William W. Kwok et al. · 2024 · RMD Open
  35. Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives
    Fujing Sun, Xiaozhuo Gao, Wentao Wang, Xiaoyan Zhao, Jingdong Zhang, Yanmei Zhu · 2025 · Frontiers in Immunology
  36. Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia
    Patrick Harrington, Richard James Dillon, Deepti H. Radia, Philippe H. Rousselot, Donal P. McLornan, Mark Ong, Anna C. Green, Alessandro Verde, Farzana Hussain, Kavita K Raj et al. · 2023 · Haematologica
  37. In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki, Koichi Jinushi, Naoko Higuchi, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Takuro Saito, Atsunari Kawashima et al. · 2024 · BMC Cancer
  38. Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity
    Xiaosheng Tan, Xiangli Zhao, Zunsong Hu, Ding‐Sheng Jiang, Zhibo Ma, Lingjuan Sun, Jingzeng Wang, Xia Huang, Bin Xie, Mi Wu et al. · 2025 · Nature Communications
  39. Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC
    Chien‐Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng‐Heng Wu, Tsung‐Han Wu, J P Fan, Chung‐Wei Su, Po‐Ting Lin, Chien‐Wei Peng, Chan‐Keng Yang et al. · 2025 · Hepatology
  40. Characterization of KIR + NKG2A + Eomes− NK‐like CD8+ T cells and their decline with age in healthy individuals
    Dimitri Kasakovski, Xiangbo Zeng, Jing Lai, Zhi Hui Yu, Danlin Yao, Shaohua Chen, Xianfeng Zha, Yangqiu Li, Ling Xu · 2020 · Cytometry Part B Clinical Cytometry
  41. Zingerone improves the immune responses in an animal model of breast cancer
    Modje Kazemi, Abdollah Jafarzadeh, Maryam Nemati, Fereshteh Taghipour, Omolbanin Oladpour, Mohammad Taghi Rezayati, Hossein Khorramdelazad, Zuhair Mohammad Hassan · 2021 · Journal of Complementary and Integrative Medicine
  42. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease
    Xia Zhang, Hui Lu, Linyi Peng, Jiaxin Zhou, Mu Wang, Jieqiong Li, Zheng Liu, Wen Zhang, Yan Zhao, Xiaofeng Zeng et al. · 2021 · Rheumatology
  43. The Immunopathobiology of SARS-CoV-2 Infection
    Milankumar Patel, Farah Shahjin, Jacob D. Cohen, Mahmudul Hasan, Jatin Machhi, Heerak Chugh, Snigdha Singh, Srijanee Das, Tanmay A. Kulkarni, Jonathan Herskovitz et al. · 2021 · FEMS Microbiology Reviews
  44. Systemic Profiling of KDM5 Subfamily Signature in Non-Small-Cell Lung Cancer
    Hao Fang · 2021 · International Journal of General Medicine
  45. Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia
    Feifei Yang, Hui Zong, Feng Li, Shulin Luo, Xiuqun Zhang, Yanli Xu, Xuezhong Zhang · 2022 · Platelets
  46. The Interplay of Transcription and Genome Topology Programs T Cell Development and Differentiation
    Xin Zhao, Shaoqi Zhu, Weiqun Peng, Hai‐Hui Xue · 2022 · The Journal of Immunology
  47. A modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling
    Asimina Petsiou, Stavroula Α. Paschou, George Vartholomatos, Katerina Chatzigianni, Nikolaos I. Kolaitis, Eleni Giotaki, George P. Bondinas, Antonis K. Moustakas, Achilleas Karamoutsios, Eleftheria K. Zervou et al. · 2019 · Cytometry Part B Clinical Cytometry
  48. Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Ken Muramatsu, Miao Zheng, Norihiro Yoshimoto, Takamasa Ito, Inkin Ujiie, Hiroaki Iwata, Hiroshi Shimizu, Hideyuki Ujiie · 2020 · Journal of Dermatological Science
  49. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma
    Shuheng Bai, Yinying Wu, Yanli Yan, Haojing Kang, Jiangzhou Zhang, Wen Ma, Ying Gao, Beina Hui, Rong Li, Xiaozhi Zhang et al. · 2020 · International Journal of Medical Sciences
  50. Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity
    Jesse Garcia Castillo, Stephanie L. Silveria, Leo Schirokauer, Antoine Sauquet, Jessica Hung, Grace Jaworski, Joseph M. Hendricks, Hei Sook Sul, James A. Olzmann, Michel J.P. DuPage · 2026 · Science Advances
  51. Immunocyte density in parathyroid carcinoma is correlated with disease relapse
    Ya Hu, Ming Cui, Yalan Bi, Xuan Zhang, M Wang, Surong Hua, Quan Liao, Yupei Zhao · 2020 · Journal of Endocrinological Investigation
  52. Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human Breast Cancer
    Jianing Yi, Siyi Tan, Yuanjun Zeng, Lianhong Zou, Jie Zeng, Chaojie Zhang, Luyao Liu, Peizhi Fan · 2022 · Scientific Reports
  53. Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
    Yidan Xia, Dongxu Wang, Yuting Piao, Minqi Chen, Duo Wang, Ziping Jiang, Bin Liu · 2022 · Frontiers in Immunology
  54. CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia
    Laurène Pousse, Koorosh Korfi, Bruno C. Medeiros, Marco Berrera, Nadine Kumpesa, Jan Eckmann, Idil Hutter-Karakoc, Vera Griesser, Vaios Karanikas, Christian Klein et al. · 2023 · Frontiers in Oncology
  55. Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effects
    Kang Miao, Li Zhang · 2023 · Chinese Medical Journal - Pulmonary and Critical Care Medicine
  56. Translational kinetic‐pharmacodynamics of mRNA‐6231, an investigational mRNA therapeutic encoding mutein interleukin‐2
    Ivana Liric Rajlic, Beatriz Guglieri-López, Nabeel Rangoonwala, Vijay D. Ivaturi, Linh M. Van, Simone Mori, Brian T. Wipke, Douglas S. Burdette, Husain Z. Attarwala · 2024 · CPT Pharmacometrics & Systems Pharmacology
  57. SWI/SNF chromatin remodeling factor BAF60b restrains inflammatory diseases by affecting regulatory T cell migration
    Xiaoqian Liu, Kuai Liu, Yuxi Wang, Xiaoyu Meng, Qianqian Wang, Sijue Tao, Qianying Xu, Xin Shen, Xianzhi Gao, Shenghui Hong et al. · 2024 · Cell Reports
  58. Exercise, autoimmune diseases and T-regulatory cells
    Miri Blank, Daphna Israeli, Yehuda Shoenfeld · 2024 · Journal of Autoimmunity
  59. Dynamics of effector and naïve Regulatory T cells throughout pregnancy
    Naoya Shigeta, Keiichi Kumasawa, Atsushi Tanaka, James B. Wing, Hitomi Nakamura, Shimon Sakaguchi, Tadashi Kimura · 2020 · Journal of Reproductive Immunology
  60. Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis
    Ran Ji, Ying Chen, Weiwei Chen, Yuming Wang, Fangchen Gong, Shunwei Huang, Rongli Xie, Ming Zhong, Zhaojun Liu, Zhitao Yang et al. · 2020 · Digestive Diseases and Sciences
  61. Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines
    José Ernesto Belizário · 2021 · Brazilian Journal of Medical and Biological Research
  62. Prognostic Model Construction and Immune Microenvironment Analysis of Breast Cancer Based on Ferroptosis-Related lncRNAs
    Cong Li Jia, Yang Fu, Ruining Li · 2021 · International Journal of General Medicine
  63. Toward a Paradigm to Distinguish Distinct Functions of FOXP3+ Regulatory T Cells
    Samuel Edward Weinberg, Benjamin David Singer · 2021 · ImmunoHorizons
  64. TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8 + T cell function
    Ran Wang, Jiefang Xu, Shipeng Cheng, Zhiyang Ling, Sonam Wangmo, Jichao Yang, Fuquan Jin, Jing Wen, Xiao Jie Lu, Liyan Ma et al. · 2025 · OncoImmunology
  65. The progress and perspective of nanomedicine in modulating the tumor immune microenvironment
    Nan Lin, Keqin Tan, Yuhao Wei, Songtao Xie, Jiaming Liu, Xuelei Ma · 2025 · Acta Pharmaceutica Sinica B
  66. Spatial transcriptomics reveals immune-stromal crosstalk within the synovium of patients with juvenile idiopathic arthritis
    Jun Inamo, Roselyn Fierkens, Michael R. Clay, Anna Helena Jonsson, Clara Lin, Kari Hayes, Nathan D. Rogers, Heather Leach, Kentaro Yomogida · 2025 · JCI Insight
  67. Antigen Processing, Presentation, and Tolerance: Role in Autoimmune Skin Diseases
    Jörg C. Prinz · 2021 · Journal of Investigative Dermatology
  68. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing
    Kang qiang Weng, Jin Yu Liu, Li Hu, Lin Lu She, Jun Qiu, Hao Qi, Hui Yue Qi, Yong-Sheng Li, Ying Dai · 2024 · International Immunopharmacology
  69. Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
    Gautham Gampa, Phillip C. Spinosa, Jennifer A. Getz, Yu Min Zhong, Wendy Halpern, Emel Esen, John Davies, Cassie K. Chou, Mandy Kwong, Yingyun Wang et al. · 2024 · British Journal of Pharmacology
  70. CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness
    Xiaodan Qin, Andrew Lam, Xu Zhang, Satyaki Sengupta, Julian Bryan Iorgulescu, Hongru Ni, Sanjukta Das, Madison Rager, Zhenwei Zhou, Tao Zuo et al. · 2024 · Science Advances
  71. Transcriptional switches in melanoma T Cells: Facilitating polarizing into regulatory T cells
    Tengda Li, Tianqin Wu, Xiang Li, Cheng Qian · 2024 · International Immunopharmacology
  72. Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice
    L Zhang, Houru Liu, Jie Shen, Wenting Liu, Dahai Liu, Liansheng Cheng, Bei Huang · 2024 · Immunobiology
  73. Precision Spatial Control of Tumor‐Stroma Interactions in Cancer Models via 3D Bioprinting for Advanced Research and Therapy
    Yan Li, Haijun Cui, Haitao Cui · 2025 · Advanced Functional Materials
  74. Bone marrow microenvironment in myelodysplastic neoplasms: insights into pathogenesis, biomarkers, and therapeutic targets
    Forouzan Bahmani, Maryam Shayanmanesh, Mahdi Safari, Amirarsalan Alaei, Yasaman Pouriafar, Zahra Rasti, Farhad Zaker, Shahrbano Rostami, Fatemeh Damerchiloo, Majid Safa · 2025 · Cancer Cell International
  75. Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance
    Wanli Zhang, He Zhang, Yiru Gao, Jianjun Lei, Chenhao Suo · 2025 · Frontiers in Cellular and Infection Microbiology
  76. The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
    Hamidreza Hassanian, Zahra Asadzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antoine Dufour, Nazanin Rostami Khosroshahi, Souzan Najafi, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran · 2022 · Frontiers in Immunology
  77. Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity
    Kalliopi Domvri, Savvas Petanidis, Paul Zarogoulidis, Doxakis Anestakis, Charalampos Charalampidis, Drosos Tsavlis, Haidong Huang, Lutz Freitag, Wolfgang Hohenforst‐Schmidt, Dimitris Matthaios et al. · 2022 · International Journal of Nanomedicine
  78. Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis
    Manuela Llano-León, Laura Camila Martínez-Enriquez, Oscar Mauricio Rodríguez Bohórquez, Esteban Alejandro Velandia Vargas, Nicolás Lalinde-Ruiz, Maria Alejandra Villota-Álava, Ivón Johanna Rodríguez, María del Pilar Montilla Velásquez, Carlos Parra-López · 2023 · PLoS ONE
  79. De novo fatty-acid synthesis protects invariant NKT cells from cell death, thereby promoting their homeostasis and pathogenic roles in airway hyperresponsiveness
    Jaemoon Koh, Yeon Duk Woo, Hyun Jung Yoo, Jun‐Pyo Choi, Sae‐Hoon Kim, Yoon‐Seok Chang, Kyeong Cheon Jung, Ji Hyung Kim, Yoon Kyung Jeon, Hye Young Kim et al. · 2023 · eLife
  80. Regulatory T cells in lung disease and transplantation
    Peizhen Lao, Jingyi Chen, Longqian Tang, Jiwen Zhang, Yuxi Chen, Yuyin Fang, Xingliang Fan · 2023 · Bioscience Reports
  81. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma
    Yong Wang, Lisha Peng, Feng Wang · 2024 · Cancer Biology & Therapy
  82. mTORC1 Inhibition Protects Human Regulatory T Cells From Granzyme-B-Induced Apoptosis
    Siawosh K. Eskandari, Hazim Allos, Basmah S. Al Dulaijan, Gandolina Melhem, Ina Sulkaj, Juliano B. Alhaddad, Anis J. Saad, Christa A. Deban, Philip Chu, John Yongjoon Choi et al. · 2022 · Frontiers in Immunology
  83. The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment
    Yuhe Li, Xiufang Ren, Wei Gao, Ruikai Cai, Jianqi Wu, Tianqi Liu, Xin Chen, Daoming Jiang, Chong Chen, Quan Cheng et al. · 2024 · CNS Neuroscience & Therapeutics
  84. Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease
    Tegan McTaggart, Jing Xuan Lim, Katie J Smith, Bronagh Heaney, David J. McDonald, Gillian Hulme, Rafiqul Hussain, Jonathan M Coxhead, Abbie Ea Degnan, John Dudley Isaacs et al. · 2024 · Journal of Biological Chemistry
  85. Association between somatic microsatellite instability, hypermutation status, and specific T cell subsets in colorectal cancer tumors
    Claire Elizabeth Thomas, Yasutoshi Takashima, Evertine Wesselink, Tomotaka Ugai, Robert S. Steinfelder, Daniel D. Buchanan, Conghui Qu, Li Hsu, Andressa Dias Costa, Steve Gallinger et al. · 2024 · Frontiers in Immunology
  86. Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications
    Niti Sureka, Sufian Zaheer · 2025 · Cell Biology International
  87. Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer
    Jing Li, Haojun Huang, Renxian Xie, Rongying Yang, Haitao Wang, Li Wan · 2025 · Frontiers in Immunology
  88. Induction of immune tolerance in NMOSD and MOGAD
    Jorge Daniel Correale, Edgar Carnero Contentti · 2025 · Therapeutic Advances in Neurological Disorders
  89. Decreased numbers and sex-based differences of circulating regulatory T cells in patients with seropositive undifferentiated arthritis
    Hong-Qing Niu, Chenrui Yuan, Chenglan Yan, Na Li, Yuansheng Lei, Xuxu Li, Jinli Ru, Xiaofeng Li · 2021 · Therapeutic Advances in Chronic Disease
  90. Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies
    Natalia Krajewska, Rémi Fiancette, Ye Htun Oo · 2022 · International Journal of Molecular Sciences
  91. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors
    Tomonori Kamiya, Naoko Ohtani · 2022 · International Immunology
  92. Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients
    Chumut Phanthunane, Rebecca Wijers, Maria J. De Herdt, Senada Koljenović, Stefan Sleijfer, Robert J. Baatenburg de Jong, José A. Hardillo, Reno Debets, Hayri Emrah Balcioglu · 2022 · Cancers
  93. Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients
    Yuchao Fei, Yifan Cao, Yun Gu, Hanji Fang, Yifan Chen, Jieti Wang, Xin Liu, Kunpeng Lv, Xudong He, Chao Lin et al. · 2021 · Cancer Immunology Immunotherapy
  94. The potential application of PD-1 blockade therapy for early-stage biliary tract cancer
    Kumiko Umemoto, Yosuke Togashi, Yasuhito Arai, Hiromi K. Nakamura, Shinichiro Takahashi, Tokiyoshi Tanegashima, Mikiya Kato, Tsubasa Nishikawa, Daisuke Sugiyama, Motohiro Kojima et al. · 2019 · International Immunology
  95. Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
    Alejandra Martínez, Jean‐Pierre Delord, Maha Ayyoub, Christel Devaud · 2020 · Cancers
  96. Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC
    Baowen Zhuo, Qifan Zhang, Tingyan Xie, Yidan Wang, Zhengliang Chen, Daming Zuo, Bo Guo · 2023 · Cellular and Molecular Life Sciences
  97. Mono-Carbonyl Curcumin Analogs for Cancer Therapy
    Takashi Maruyama, Hiroyuki Yamakoshi, Yoshiharu Iwabuchi, Hiroyuki Shibata · 2023 · Biological and Pharmaceutical Bulletin
  98. The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
    Wentao Jia, Jiaying Yuan, Shu Li, Binbin Cheng · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  99. Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature
    Qichao Hong, Shun Ding, Chengliang Xing, Zhonglin Mu · 2024 · Medicine
  100. Prognostic value of tumor‐infiltrating lymphocytes and PD ‐ L1 expression in esophageal squamous cell carcinoma
    Jie Hu, Takeshi Toyozumi, Kentaro Murakami, Satoshi Endo, Yasunori Matsumoto, Ryota Otsuka, Tadashi Shiraishi, Shinichiro Iida, Hiroki Morishita, Tenshi Makiyama et al. · 2024 · Cancer Medicine